Literature DB >> 26043691

Src tyrosyl phosphorylates cortactin in response to prolactin.

Alan Hammer1, Sneha Laghate2, Maria Diakonova3.   

Abstract

The hormone/cytokine prolactin (PRL) is implicated in breast cancer cell invasion and metastasis. PRL-induced pathways are mediated by two non-receptor tyrosine kinases, JAK2 and Src. We previously demonstrated that prolactin stimulates invasion of breast cancer cells TMX2-28 through JAK2 and its target serine/threonine kinase PAK1. We hypothesize herein that the actin-binding protein cortactin, a protein involved in invadopodia formation and cell invasion, is activated by PRL. We demonstrate that TMX2-28 cells are more invasive than T47D breast cancer cells in response to PRL. We determine that cortactin is tyrosyl phosphorylated in response to PRL in a time and dose-dependent manner in TMX2-28 cells, but not in T47D cells. Furthermore, we show that PRL mediates cortactin tyrosyl phosphorylation via Src, but not JAK2. Finally, we demonstrate that maximal PRL-mediated TMX2-28 cell invasion requires both Src and JAK2 kinase activity, while T47D cell invasion is JAK2- but not Src-dependent. Thus PRL may induce cell invasion via two pathways: through a JAK2/PAK1 mediated pathway that we have previously demonstrated, and Src-dependent activation and tyrosyl phosphorylation of cortactin.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell invasion; Cortactin; JAK2 kinase; Prolactin; Src kinase; Tyrosine kinase

Mesh:

Substances:

Year:  2015        PMID: 26043691      PMCID: PMC4497854          DOI: 10.1016/j.bbrc.2015.05.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  Src is required for cell migration and shape changes induced by fibroblast growth factor 1.

Authors:  J Liu; C Huang; X Zhan
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

2.  Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner.

Authors:  L Crostella; S Lidder; R Williams; G G Skouteris
Journal:  Oncogene       Date:  2001-06-21       Impact factor: 9.867

3.  Prolactin as a chemoattractant for human breast carcinoma.

Authors:  M V Maus; S C Reilly; C V Clevenger
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

Review 4.  Tyrosine kinase inhibition: an approach to drug development.

Authors:  A Levitzki; A Gazit
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

5.  Role of prolactin/prolactin receptor signaling in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Breast Dis       Date:  2003

Review 6.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

7.  Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.

Authors:  Emma T Bowden; Ena Onikoyi; Rebecca Slack; Akira Myoui; Toshiyuki Yoneda; Kenneth M Yamada; Susette C Mueller
Journal:  Exp Cell Res       Date:  2006-01-25       Impact factor: 3.905

8.  Prolactin receptor is associated with c-src kinase in rat liver.

Authors:  J J Berlanga; J A Fresno Vara; J Martín-Pérez; J P García-Ruiz
Journal:  Mol Endocrinol       Date:  1995-11

9.  JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization.

Authors:  H Rui; J J Lebrun; R A Kirken; P A Kelly; W L Farrar
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

10.  The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells.

Authors:  C Huang; J Liu; C C Haudenschild; X Zhan
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

View more
  3 in total

1.  Selective Adhesive Cell Capture without Molecular Specificity: New Surfaces Exploiting Nanoscopic Polycationic Features as Discrete Adhesive Units.

Authors:  S Kalasin; E P Browne; K F Arcaro; M M Santore
Journal:  RSC Adv       Date:  2017-02-28       Impact factor: 3.361

Review 2.  Cortactin in cancer cell migration and invasion.

Authors:  Miao Yin; Wenqing Ma; Liguo An
Journal:  Oncotarget       Date:  2017-09-19

3.  Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis.

Authors:  Md Kamrul Hasan; George F Widhopf; Suping Zhang; Sharon M Lam; Zhouxin Shen; Steven P Briggs; Barbara A Parker; Thomas J Kipps
Journal:  NPJ Breast Cancer       Date:  2019-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.